JP Morgan Maintains Overweight on Nuvalent, Lowers Price Target to $145

Benzinga · 1d ago
JP Morgan analyst Anupam Rama maintains Nuvalent (NASDAQ:NUVL) with a Overweight and lowers the price target from $147 to $145.